Suchergebnisse - "Liang, Bingyu"

PubPharm (8)

1

Transmission network and phylogenetic analysis reveal older male-centered transmission of CRF01_AE and CRF07_BC in Guangxi, China

enthalten in: Emerging microbes & infections | 2023

von Zhang, F. | Yang, Y. | Liang, N. | +13

2

Epidemiological profile and molecular genetic characterization of HIV-1 among female sex workers and elderly male clients in Guangxi, China

enthalten in: Emerging microbes & infections | 2021

von Chen, X. | Qin, C. | Chen, R. | +15

3

HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China : a large-scale cross-sectional study

enthalten in: AIDS research and therapy | 2019

von Hu, X. | Liang, B. | Zhou, C. | +16

4

HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study

enthalten in: AIDS research and therapy | 2019

von Hu, X. | Liang, B. | Zhou, C. | +16

5

HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study

enthalten in: AIDS research and therapy | 2019

von Hu, X. | Liang, B. | Zhou, C. | +16

6

Dolutegravir(DTG, S/GSK1349572) combined with other ARTs is superior to RAL- or EFV-based regimens for treatment of HIV-1 infection: a meta-analysis of randomized controlled trials

enthalten in: AIDS research and therapy | 2016

von Jiang, J. | Xu, X. | Guo, W. | +8

7

Dolutegravir(DTG, S/GSK1349572) combined with other ARTs is superior to RAL- or EFV-based regimens for treatment of HIV-1 infection: a meta-analysis of randomized controlled trials

enthalten in: AIDS research and therapy | 2016

von Jiang, J. | Xu, X. | Guo, W. | +8

8

Dolutegravir(DTG, S/GSK1349572) combined with other ARTs is superior to RAL- or EFV-based regimens for treatment of HIV-1 infection : a meta-analysis of randomized controlled trials

enthalten in: AIDS research and therapy | 2016

von Jiang, J. | Xu, X. | Guo, W. | +8

1
[1]